(Q39269740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lisa Maher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

J Grebely

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

L Topp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

H Wand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Dore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

198-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438681%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis C virus infection

5 March 2020

cites work

1 reference

Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity

21 January 2018

1 reference

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis

21 January 2018

1 reference

Hepatitis C treatment for injection drug users: a review of the available evidence

21 January 2018

1 reference

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

21 January 2018

1 reference

Limited uptake of hepatitis C treatment among injection drug users

21 January 2018

1 reference

Antiviral therapy for hepatitis C: why are so few patients being treated?

21 January 2018

1 reference

Public health impact of antiviral therapy for hepatitis C in the United States

21 January 2018

1 reference

Rate and predictors of treatment prescription for hepatitis C.

21 January 2018

1 reference

Market uptake of new antiviral drugs for the treatment of hepatitis C.

21 January 2018

1 reference

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

21 January 2018

1 reference

The changing therapeutic landscape for hepatitis C.

21 January 2018

1 reference

A watershed moment in the treatment of hepatitis C.

21 January 2018

1 reference

Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey

21 January 2018

1 reference

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

21 January 2018

1 reference

Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study

21 January 2018

1 reference

A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective

21 January 2018

1 reference

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection

21 January 2018

1 reference

Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors

21 January 2018

1 reference

Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.

21 January 2018

1 reference

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals

21 January 2018

1 reference

Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels

21 January 2018

1 reference

Hepatitis C in HIV-infected individuals: cure and control, right now.

21 January 2018

1 reference

Barriers to the treatment of hepatitis C. Patient, provider, and system factors

21 January 2018

1 reference

An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community

21 January 2018

1 reference

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

21 January 2018

1 reference

Outcomes of treatment for hepatitis C virus infection by primary care providers

21 January 2018

1 reference

Capacity enhancement of hepatitis C virus treatment through integrated, community-based care

21 January 2018

1 reference

Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program

21 January 2018

1 reference

Treatment of chronic hepatitis C in a state correctional facility

21 January 2018

1 reference

Treatment of chronic hepatitis C in Canadian prison inmates

21 January 2018

1 reference

Hepatitis C: the end of the beginning and possibly the beginning of the end.

21 January 2018

1 reference

Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users

21 January 2018

1 reference

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

21 January 2018

1 reference

Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney

21 January 2018

1 reference

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

21 January 2018

1 reference

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

21 January 2018

1 reference

Mathematical modelling of hepatitis C treatment for injecting drug users

21 January 2018

1 reference